Bei Benutzung wird die Seite neugeladen
Barrierefreie Anpassungen
Wählen Sie Ihre Einstellungen
Seheinschränkungen Unterstützung für Menschen, die schlecht sehen
Texte vorlesen Hilfestellung für Nutzer, die Probleme beim Lesen von Onlinetexten haben
Kognitive Einschränkungen Hilfestellung beim Lesen und beim Erkennen wichtiger Elemente
Neigung zu Krampfanfällen Animationen werden deaktiviert und gefährliche Farbkombinationen reduziert
Konzentrationsschwäche Ablenkungen werden reduziert und ein klarer Fokus gesetzt
Screenreader Die Website wird so verändert, das sie mit Screenreadern kompatibel ist
Tastatursteuerung Die Webseite kann mit der Tastatur genutzt werden
Alle Einstellungen zurücksetzen Ihre Einstellungen zur Barrierefreiheit werden auf den Standard zurückgesetzt
Individuelle Anpassungen
Schriftgröße
Zeilenabstand
Inhaltsgröße
Wortabstand
Zeichenabstand
Hintergrundfarbe
Textfarbe
Linkfarbe
Titelfarbe

Extracellular vesicles (EVs) are non-replicating, lipid bilayer-enclosed particles secreted by virtually all cell types. These vesicles serve as intercellular messengers, carrying a diverse cargo of proteins, lipids, nucleic acids, and organelles from their parental cells to mediate complex cellular communication. EVs are classified into three main categories based on their size and origin:

Due to challenges in separating specific EV subsets and a lack of definitive characterization markers, the International Society for Extracellular Vesicles (ISEV) recommends using the generic term “EV“. However, it is widely believed that the therapeutic potential of EVs primarily lies in the exosome-sized subset, often referred to as small EVs (sEVs). When derived from the appropriate cell type, sEVs have been shown to promote neurological recovery, neuronal survival, and brain remodeling.

In collaboration with Prof. Bernd Giebel at the Institute for Transfusion Medicine, University Hospital Essen, our research focuses on the translational application of mesenchymal stromal cell-derived small extracellular vesicles (MSC-sEVs) in a mouse model of ischemic stroke induced by transient middle cerebral artery occlusion (MCAO).

Key Research areas:

  1. Neuroprotection: Evaluating the therapeutic potential of sEVs derived from MSCs cultured under various conditions (e.g., normoxia, hypoxia) or genetically engineered MSCs during the acute phase of stroke. To enhance clinical relevance, the impact of stroke-related comorbidities, such as aging and hyperlipidemia, on MSC-sEV-mediated neuroprotection is also investigated.
  2. Angiogenesis and Neurogenesis: Investigating the role of MSC-sEVs in promoting vascular regeneration and neural repair during the chronic phase of stroke recovery.
  3. Immunomodulation: Exploring how MSC-sEVs modulate immune responses, particularly by mitigating neuroinflammation through their interaction with peripheral immune cells.

Additional Interests:

Beyond MSC-sEVs, we are also exploring EVs derived from other cell types, including immune cells (e.g., neutrophils and monocytes/macrophages) and non-immune cells (e.g., platelets, endothelial cells, and neurons) to understand their potential therapeutic applications in neurological disorders.

Publications

Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression. Doeppner, T.R., Herz, J., Gorgens, A., Schlechter, J., Ludwig, A.K., Radtke, S., de Miroschedji, K., Horn, P.A., Giebel, B., and Hermann, D.M. (2015). Stem Cells Transl Med 4, 1131-1143.

Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils. Wang, C., Börger, V., Sardari, M., Murke, F., Skuljec, J., Pul, R., Hagemann, N., Dzyubenko, E., Dittrich, R., Gregorius, J., Hasenberg, M., Kleinschnitz, C., Popa-Wagner, A., Doeppner, T.R., Gunzer, M., Giebel, B., and Hermann, D.M. (2020). Stroke 51, 1825-1834.

Small extracellular vesicles obtained from hypoxic mesenchymal stromal cells have unique characteristics that promote cerebral angiogenesis, brain remodeling and neurological recovery after focal cerebral ischemia in mice. Gregorius, J., Wang, C., Stambouli, O., Hussner, T., Qi, Y., Tertel, T., Börger, V., Yusuf, A.M., Hagemann, N., Yin, D., Dittrich, R., Mouloud, Y., Mairinger, F.D., Magraoui, Fouzi E., Popa-Wagner, A., Kleinschnitz, C., Doeppner, T.R., Gunzer, M., Meyer, H.E., Giebel, B., and Hermann, D.M. (2021). Basic Res. Cardiol. 116, 40.

Postischemic Neuroprotection Associated With Anti-Inflammatory Effects by Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles in Aged Mice. Wang, C., Börger, V., Yusuf, A.M., Tertel, T., Stambouli, O., Murke, F., Freund, N., Kleinschnitz, C., Herz, J., Gunzer, M., Popa-Wagner, A., Doeppner, T.R., Giebel, B., and Hermann, D.M. (2022). Stroke 53, e14-e18.

Neuroprotective and neurorestorative actions of mesenchymal stromal cell-derived small extracellular vesicles in the ischemic brain. Wang, C., Giebel, B., and Hermann, D.M. (2022). Exploration of Neuroscience 1, 61-74.

Extracellular vesicles set the stage for brain plasticity and recovery by multimodal signalling. Hermann, D.M., Peruzzotti-Jametti, L., Giebel, B., and Pluchino, S. (2023). Brain 147, 372-389.

Chen Wang, MD, PhD

Postdoc

E-Mail
Steckbrief

Ayan Mohamud Yusuf, PhD

Post-doctoral scientist

E-Mail
Steckbrief

Ulf Brockmeier, PhD

Postdoc

E-Mail
Steckbrief

Xiaolong Liu, MSc

MD student

E-Mail
Steckbrief

Yiqiao Zhang, MSc

PhD student

E-Mail
Steckbrief

Britta Kaltwasser

Biotechnical Assistant

E-Mail
Steckbrief